Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 325 publications
Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective.
Journal: Informatics in medicine unlocked
Published: October 14, 2022
Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach.
Journal: Expert opinion on drug discovery
Published: May 25, 2022
Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 14, 2022
Using a high-throughput, whole-cell hydrogenase assay to identify potential small molecule inhibitors of [NiFe]-hydrogenase.
Journal: Metallomics : integrated biometal science
Published: December 20, 2021
Identification of Promising Antifungal Drugs against Scedosporium and Lomentospora Species after Screening of Pathogen Box Library.
Journal: Journal of fungi (Basel, Switzerland)
Published: August 28, 2021
Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach.
Journal: Informatics in medicine unlocked
Published: July 28, 2021
Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis.
Journal: Bioorganic chemistry
Published: March 23, 2021
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.
Journal: Pharmacological research
Published: April 09, 2020
A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Journal: PloS one
Published: February 07, 2020
Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.
Journal: Antimicrobial agents and chemotherapy
Published: October 18, 2019
Last Updated: 10/31/2025